
Spravato Reimbursement Rates by State: What Blue Cross Plans Pay for G2083 and J0013 (2026)
Blue Cross plans in seven states pay a median of $850.52 to $2,001.69 for an 84 mg Spravato session (G2083). The drug for that session costs about $1,288, so in five of the seven states the median rate does not cover it.
We compared the plans’ own published rate files in California, Illinois, Colorado, Virginia, Florida, Texas and New York. Each is a separate company with its own contracts, and the data comes from different months, from July to October 2026, shown in the table.
How much of each plan the files cover differs.
- Illinois, Virginia and Texas. We pooled the plan’s network files, which cover all or nearly all of its commercial plans.
- California, Colorado and New York. We used one Anthem network file per state, so Anthem’s other networks there may pay differently.
- Florida. We used Florida Blue’s group network files. Its individual plan files could not be downloaded, and only 70 office prescribers have rates, so treat Florida as a small sample.
In every state we kept dollar rates for professional claims in the office setting, for psychiatrists and psychiatric nurse practitioners who practice in that state according to the federal NPI registry.
What Do Blue Cross Plans Pay for a Spravato Session in Each State?
Anthem in California pays the most for G2083, more than twice the median at Anthem in New York, which pays the least.
| Payer | State | Median Rate | Mean Rate | Min | Max | Unique NPI Count | Data Month |
|---|---|---|---|---|---|---|---|
| Anthem | California | $2,001.69 | $2,822.01 | $408.44 | $6,307.07 | 3,263 | September 2026 |
| BCBS of Illinois | Illinois | $1,305.53 | $1,345.88 | $886.54 | $4,061.30 | 2,567 | September 2026 |
| Anthem | Colorado | $1,260.44 | $1,427.59 | $1,071.37 | $4,829.49 | 1,303 | October 2026 |
| Anthem | Virginia | $1,215.94 | $1,295.21 | $51.57 | $3,226.53 | 1,998 | October 2026 |
| Florida Blue | Florida | $1,100.21 | $1,098.40 | $459.43 | $1,343.49 | 70 | July 2026 |
| BCBS of Texas | Texas | $866.11 | $947.82 | $665.42 | $3,015.71 | 5,803 | August 2026 |
| Anthem | New York | $850.52 | $1,080.49 | $553.09 | $5,642.21 | 5,303 | September 2026 |
Rates for HCPCS G2083 (office visit with esketamine self-administration over 56 mg, including 2 hours of observation) from each plan’s machine readable files. Median and mean are over distinct clinician and rate pairs.
G2083 is a bundled code. It pays for the drug, the session and the two hours of observation in one amount. So the number that matters is what is left after the drug.
Does the Spravato Rate Cover the Drug in Each State?
For psychiatrists in four states, yes. For nurse practitioners, only in California. We subtracted the cost of an 84 mg dose, $1,288.12 at the October 21, 2026 national average drug acquisition cost (NADAC), from each license’s median G2083 rate.
| State | Psychiatrist median | Psychiatrist after the drug | Nurse practitioner median | Nurse practitioner after the drug | Prescribers with a rate that covers the drug |
|---|---|---|---|---|---|
| California | $2,220.37 | $932.25 left | $1,428.39 | $140.27 left | 98% |
| Virginia | $1,430.52 | $142.40 left | $1,155.14 | $132.98 short | 70% |
| Illinois | $1,365.92 | $77.80 left | $1,161.03 | $127.09 short | 54% |
| Colorado | $1,317.74 | $29.62 left | $1,260.44 | $27.68 short | 30% |
| Florida | $1,168.85 | $119.27 short | $1,038.97 | $249.15 short | 2 of 70 |
| Texas | $1,018.95 | $269.17 short | $866.11 | $422.01 short | 11 of 5,803 |
| New York | $850.52 | $437.60 short | $850.52 | $437.60 short | 24% |
The last column counts office prescribers who have at least one G2083 rate of $1,288.12 or more in the files. Many prescribers have several rates under different contracts, so having a covering rate does not mean every claim is paid at it.
What is left also has to pay for two hours of a room, staff time and the clinician. A few dollars left is not a profit.
Your own drug price may differ from the national average. Practices buy Spravato through specialty distributors, so put your invoice price in place of ours.
Why Does California Look So Different?
Because a group of very high rates pulls its median up. The most common California rate, $1,347.54, leaves only $59.42 after the drug, and 543 prescribers have it. The second most common, $5,040.28, belongs to 242 prescribers.
So nearly every California prescriber has a rate that covers the drug, but for many of them the margin is thin. Check which group your contract is in before you buy stock.
New York has the opposite pattern. Its median does not cover the drug, but 24 percent of prescribers have at least one rate that does, such as $1,984.21 for 207 psychiatrists.
Can You Bill the Drug Separately With J0013?
Usually not if your practice buys the drug. Anthem’s coding tips for New York, Colorado and Virginia tell practices that buy Spravato to bill G2082 or G2083 alone, with no separate charge for the drug. Those tips date from 2022, before J0013 replaced the old drug code on January 1, 2026.
Still, most of these plans list a J0013 rate, so it is worth asking in writing. J0013 pays for the drug per milligram, so an 84 mg dose is billed as 84 units. At the median rates, those 84 units would pay more than the drug costs in five states.
| State | J0013 median per mg | 84 mg dose pays | After the drug |
|---|---|---|---|
| California | $19.18 | $1,611.12 | $323.00 left |
| Colorado | $16.30 | $1,369.20 | $81.08 left |
| Florida | $16.30 | $1,369.20 | $81.08 left |
| New York | $15.98 | $1,342.32 | $54.20 left |
| Virginia | $15.34 | $1,288.56 | 44 cents left |
| Texas | $15.02 | $1,261.68 | $26.44 short |
- Illinois. Blue Cross Blue Shield of Illinois lists a dollar J0013 rate for only three office prescribers, so for nearly everyone the drug is paid only through G2082 and G2083.
- Colorado. Only 405 of 1,303 office prescribers have a J0013 rate.
- Florida. We found no Florida Blue rule on whether a practice can bill J0013 instead of G2083.
The difference is largest in New York. There, G2083 pays $437.60 less than an 84 mg dose costs, while 84 units of J0013 would pay $54.20 more than the dose costs. But Anthem’s New York coding tips tell practices that buy the drug to bill G2083, so get the plan’s answer in writing before you bill J0013.
What This Means for Your Practice
Whether to buy and bill Spravato depends on your state, your license and your contract. Three things follow.
- Run the math on your own rates. Take your G2083 rate and your invoice price for an 84 mg dose. If the gap does not pay for two hours of observation, the specialty pharmacy route is safer.
- Nurse practitioners should be cautious outside California. In Virginia, Illinois, Colorado, Florida, Texas and New York, the median nurse practitioner rate does not cover an 84 mg dose.
- Ask before you bill J0013. It would cover the drug in New York and Florida, where G2083 does not, but Anthem’s coding tips say practices that buy the drug should bill G2083. Get the plan’s answer in writing.
Disclaimer: This article uses rate information from the Machine Readable Files that Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Illinois, Florida Blue and Blue Cross and Blue Shield of Texas publish under the federal Transparency in Coverage rule. Each state’s figures come from that plan’s own files, read with the same filters. Drug costs use the federal NADAC survey, which measures what retail pharmacies pay and may differ from what a practice pays. This analysis covers seven plans in seven states and will not reflect every insurer or network. Healthcare pricing and coverage policy change frequently, and individual circumstances affect actual payment. Practices should verify current rates, billing rules and drug prices before relying on them for billing or purchasing decisions.
Fuse reads your paid claims and shows what each payer actually pays you per CPT code, next to these medians.

Fuse builds a model of payer behavior from your claims: underpayments flagged, lapsed plans caught, coverage predicted for scheduled patients.
Get Your Free Revenue AnalysisFAQs
What is the reimbursement rate for G2083?
It depends on the plan and the state. Across the seven Blue Cross plans we analyzed, the median office rate for G2083 (a Spravato session over 56 mg) runs from $850.52 at Anthem in New York to $2,001.69 at Anthem in California. The rate has to cover the drug, which costs about $1,288 for an 84 mg dose.
Does buying and billing Spravato make money?
Only in some states and for some licenses. At the median, an 84 mg session leaves money after the drug for California psychiatrists and nurse practitioners, and for psychiatrists in Illinois, Virginia and Colorado. In Florida, Texas and New York the median rate is below the drug cost for both.
What is the reimbursement rate for J0013?
J0013 pays for the drug alone, per 1 mg. Medians run from $15.02 per mg at Blue Cross Blue Shield of Texas to $19.18 at Anthem in California. Blue Cross Blue Shield of Illinois lists a J0013 rate for only three office prescribers.








